Currently Browsing

Our Products

Fesoterodine Fumarate Extended-Release Tablets 4 mg – 30/Bottle

Overview

Reference Brand:
Toviaz®
Therapeutic Class:
Fesoterodine

Specifications

GCN:
99711
Strength:
4 mg
Size:
30
NDC #:
65862076630
TE Code:
AB

Order Information

Case Qty (min order qty):
48
Case Weight (lbs):
4.768

Attributes

Physical Form:
Tablets
Shape:
Tablets
Color:
Light blue
Imprint:
"K46"
Prescribing Info
Product News

April 15, 2025 | Aurobindo Receives FDA Approval for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 10 mg ... Read more

Product News

April 15, 2025 | Aurobindo Receives FDA Approval for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 5 mg, 20 mg, and 40 mg ... Read more

Product News

April 14, 2025 | Aurobindo Receives FDA Approval for Allopurinol Tablets USP, 100 mg and 300 mg ... Read more